Literature DB >> 15849526

Estimates of primary and secondary syphilis rates in persons with HIV in the United States, 2002.

Harrell W Chesson1, James D Heffelfinger, Richard F Voigt, Dayne Collins.   

Abstract

BACKGROUND: In the United States, there is a high rate of HIV coinfection in persons with syphilis. GOAL: The goal of this study was to estimate the rate of primary and secondary (P&S) syphilis in persons living with HIV in the United States in 2002. STUDY: We approximated the number of new cases of P&S syphilis in HIV-infected persons and divided this by the estimated number of persons living with HIV. Values for the calculations were obtained from national syphilis and HIV/AIDS surveillance reports and other published sources.
RESULTS: We estimated the rate of new cases of P&S syphilis at 186 per 100,000 persons living with HIV in 2002, 25 per 100,000 HIV-infected women, 60 per 100,000 HIV-infected men who have sex with women only, and 336 per 100,000 HIV-infected men who have sex with men. Of the 6862 reported cases of P&S syphilis in 2002, an estimated 1718 (25%) occurred in persons coinfected with HIV.
CONCLUSIONS: The estimated rate of P&S syphilis in persons with HIV is considerably higher than that of the general population. These findings highlight the importance of providing sexually transmitted disease prevention and control services to HIV-infected persons.

Entities:  

Mesh:

Year:  2005        PMID: 15849526     DOI: 10.1097/01.olq.0000162359.75509.9c

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  23 in total

1.  Shared communities, structural contexts, and HIV risk: prioritizing the HIV risk and prevention needs of Black heterosexual men.

Authors:  Lisa Bowleg; Anita Raj
Journal:  Am J Public Health       Date:  2012-03-08       Impact factor: 9.308

Review 2.  Syphilis: using modern approaches to understand an old disease.

Authors:  Emily L Ho; Sheila A Lukehart
Journal:  J Clin Invest       Date:  2011-12-01       Impact factor: 14.808

3.  Cultural reflexivity in health research and practice.

Authors:  Robert Aronowitz; Andrew Deener; Danya Keene; Jason Schnittker; Laura Tach
Journal:  Am J Public Health       Date:  2015-04-23       Impact factor: 9.308

4.  International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-10-23       Impact factor: 5.396

5.  Rising Syphilis Infection among Rural HIV-Infected Men who Routinely Received Risk-Reduction Counseling: New Challenges to HIV Prevention in Clinical Care.

Authors:  Poonam Mathur; John Zurlo; Patsi Albright; Tonya Crook; Cynthia Whitener; Ping Du
Journal:  J AIDS Clin Res       Date:  2014

Review 6.  Rabbit Models for Studying Human Infectious Diseases.

Authors:  Xuwen Peng; John A Knouse; Krista M Hernon
Journal:  Comp Med       Date:  2015-12       Impact factor: 0.982

7.  Using Sexual Orientation and Gender Identity to Monitor Disparities in HIV, Sexually Transmitted Infections, and Viral Hepatitis.

Authors:  Chelsea L Shover; Michelle A DeVost; Matthew R Beymer; Pamina M Gorbach; Risa P Flynn; Robert K Bolan
Journal:  Am J Public Health       Date:  2018-11       Impact factor: 9.308

8.  Syphilitic hepatitis among HIV-infected patients.

Authors:  N Crum-Cianflone; J Weekes; M Bavaro
Journal:  Int J STD AIDS       Date:  2009-04       Impact factor: 1.359

9.  Neurocognitive impairment in HIV-infected individuals with previous syphilis.

Authors:  C M Marra; R Deutsch; A C Collier; S Morgello; S Letendre; D Clifford; B Gelman; J McArthur; J A McCutchan; D M Simpson; N A Duarte; R K Heaton; I Grant
Journal:  Int J STD AIDS       Date:  2013-06-14       Impact factor: 1.359

10.  Prevalence and Risk Factors of HIV, Syphilis, Hepatitis B and C Among Female Prisoners in Isfahan, Iran.

Authors:  Zary Nokhodian; Mohammad Reza Yazdani; Majid Yaran; Parisa Shoaei; Mina Mirian; Behrooz Ataei; Anahita Babak; Mehdi Ataie
Journal:  Hepat Mon       Date:  2012-07-30       Impact factor: 0.660

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.